EHRA 2021 Online Congress  The scientific programme emphasised on “Making connections to overcome arrhythmia”, not only between different subspecialities, the young and old EP colleagues, but also during the sessions.

From 10 May, EHRA Members get full access all year long to all congress presentations on ESC 365. They also benefit from exclusive educational events, networking opportunities, clinical science and daily practice tools

Topics: 

– 01 Inaugural session
– 02 New tools and recipes for atrial fibrillation ablation
– 03 Real-world evidence and outstanding clinical practice on cryoballoon Ablation
– 04 Late Breaking Clinical Trials
– 05 Innovation doesn’t end at implant – Advancing cardiac device patient management
– 06 Hein Wellens Memorial ECG Course
– 07 How to in cardiac resynchronisation
– 08 CCM therapy – Optimizing the treatment of Heart Failure with devices
– 09 Neurohormonal disturbances and arrhythmias
– 10 Physiological pacing – current and future directions
– 11 Case Reports session for EHRA
– 12 Cardiac stimulation in the third millennium
– 13 Difficult cases in atrial fibrillation ablation
– 14 NOACs in the Elderly AF patient – Learnings from 10 years of clinical practice
– 15 Less is more – Do we still need an atrial lead for atrial sensing
– 16 Promising advances in heart failure patient management
– 17 The Right Power for the Right Duration – ablate with your eyes open
– 18 Innovation in catheter ablation with real-time, temperature-controlled technology
– 19 The best of Europace Journal 2020
– 20 Structural microdomains in cardiomyocyte arrhythmogenesis
– 21 ECG competition
– 22 Scientific reports
– 23 How to avoid device complications
– 24 Challenging cases in ventricular tachycardia ablation
– 25 The year in cardiovascular medicine
– 26 Ion channel (dys)function
– 27 Live ablation atrial fibrillation
– 28 Supraventricular guidelines 2019 – an update
– 29 Pacing tips and tricks
– 30 Honorary lectures
– 31 Conversations around persistent AF hybrid therapies -1 topic, 2 continents, 3 voices
– 32 Rotational TLE – safe, efficient, and effective outcomes with PROMET and RELEASE
– 33 Advancing Imaging in Electrophysiology – current and future use of dielectric imaging
– 34 The future is here – Miniaturization in implantable cardiac devices
– 35 The new Polar Era – Saturday Morning TalkShow
– 36 Carmeliet – Coraboeuf – Weidmann Lecture
– 37 Live ablation ventricular tachycardia I
– 38 Management of arrhythmias in specific populations – paediatric, congenital and COVID-19
– 39 Sports and sudden cardiac death
– 40 Evidence based atrial fibrillation ablation
– 41 3 years of HD mapping – Do outcomes live up to expectations
– 42 Controversies in management of ventricular arrhythmias
– 43 Pacemakers and ICDs – controversies in device therapy
– 44 Atrial fibrillation live case
– 45 Digital EP new ways to– training in a new world
– 46 Digital Health – Patient and healthcare provider centric innovations in cardiac rhythm management
– 47 How do we translate the ‘2020 ESC Guidelines on Atrial Fibrillation’ into clinical practice
– 48 The future of EP practice – Do we need a mapping guided patient specific ablation strategy to treat complex arrhythmias
– 49 Best of e-Cardiology
– 50 Inherited cardiomyopathies – What´s new
– 51 Syncope – what is new in therapy
– 52 How to optimise device programming – getting the best for your buck
– 53 How to in atrial fibrillation ablation
– 54 Navigating the patient driven world of cardiac recordings
– 55 Management of patients with CIED complications; facilitating guideline implementation across Europe
– 56 What is the value of the S-ICD (Subcutaneous Implantable Cardiac Device) during a pandemic and beyond
– 57 Young Investigator Award – Basic and Translational Science
– 58 Live ablation ventricular tachycardia II
– 59 How to improve outcomes in atrial fibrillation
– 60 Cardiac arrest in Europe
– 61 Controversies in rhythm control therapy in persistent atrial fibrillation and obesity
– 62 Young Investigator Award – Clinical
– 63 2020 ESC Guidelines on Atrial Fibrillation, focus on oral anticoagulation
– 64 The utilisation of digital methods to improve prediction and recognition of cardiac arrest and to deliver health-care
– 65 Shared decision-making in devices
– 66 Ventricular tachycardia ablation – image-guided ventricular tachycardia ablation
– 67 EHRA Technology and Innovation Awards 2021
– 68 Innovative technology
– 69 What is new in syncope
– 70 EHRA expert consensus statement and practical guide on optimal implantation techniques for conventional pacemakers and ICDs
– 71 What to do if conventional ventricular tachycardia ablation fails
– 72 Robotics in EP – Now a reality
– 73 Cardiac device therapy in 2021 – Increasing the benefits, while preventing side effects
– 74 EHRA practical guide to NOAC use in atrial fibrillation
– 75 Sudden death prevention and ICD therapy – unsolved issues
– 76 Pacing manoeuvers to sort out the tachycardia mechanism
– 77 Ventricular tachycardia ablation live case
– 78 What did change in Heart Failure patient management since the last EHRA
– 79 Inherited cardiomyopathies – how to diagnose and risk stratify primary arrhythmia patients and family members
– 80 The future of electrophysiology
– 81 Closing session

Release Date : Friday, 23 April – Sunday, 25 April 2021